Abstract: Medical and Pediatric OncologyVolume 31, Issue 6 p. 531-533 Topical Topic Use of chemotherapy for retinoblastoma Charles B. Pratt MD, Corresponding Author Charles B. Pratt MD Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee Department of Pediatrics, University of Tennessee, Memphis, TennesseeSt. Jude Children's Research Hospital, Memphis, TN 38105-2794Search for more papers by this author Charles B. Pratt MD, Corresponding Author Charles B. Pratt MD Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee Department of Pediatrics, University of Tennessee, Memphis, TennesseeSt. Jude Children's Research Hospital, Memphis, TN 38105-2794Search for more papers by this author First published: 12 December 1998 https://doi.org/10.1002/(SICI)1096-911X(199812)31:6<531::AID-MPO15>3.0.CO;2-FCitations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Wolff JA, Pratt CB, Sitarz AL: Chemotherapy of metastatic retinoblastoma. Cancer Chemother Rep 16: 435–437, 1962. CASPubMedGoogle Scholar 2 Chan HSL, DeBoer G, Thiessen JJ, et al.: Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without receiving radiation. Clin Cancer Res 2: 1499–1508, 1996. CASPubMedWeb of Science®Google Scholar 3 Gallie BL, Budning A, DeBoer G, et al.: Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiation. Arch Ophthalmol 114: 1321–1329, 1996. 10.1001/archopht.1996.01100140521001 CASPubMedWeb of Science®Google Scholar 4 Murphree AL, Villablanca JG, Deegan WF III, et al.: Chemotherapy plus local therapy in the treatment of intraocular retinoblastoma. Arch Ophthalmol 14: 1348–1356, 1996. 10.1001/archopht.1996.01100140548005 Google Scholar 5 Shields CL, DePotter P, Himelstein BP, et al.: Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114: 1330–1338, 1996. 10.1001/archopht.1996.01100140530002 CASPubMedWeb of Science®Google Scholar 6 Shields JA, Shields CL, DePotter P, Needle M: Bilateral macular retinoblastoma managed by chemoinduction and chemothermo-therapy. Arch Ophthalmol 114: 1426–1427, 1996. 10.1001/archopht.1996.01100140626025 CASPubMedWeb of Science®Google Scholar 7 Chan HSL, Thorner PS, Haddad G, Gallie BL: Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology 98: 1425–1431, 1991. 10.1016/S0161-6420(91)32134-1 CASPubMedWeb of Science®Google Scholar 8 Dunkel IJ, Mendelsohn M, Bayer L, et al.: A pilot phase 2 trial of carboplatin in children with intraocular retinoblastoma. Proc Am Soc Clin Oncol 15: 459, 1996. Google Scholar 9 Doz F, Desjardins L, Quintana E, et al.: Efficacy and toxicity of neoadjuvant chemotherapy using etoposide and carboplatin in 20 patients with intraocular retinoblastoma. Med Pediatr Oncol 27: 256, 1996. Google Scholar 10 Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53: 661–671, 1986. 10.1038/bjc.1986.110 CASPubMedWeb of Science®Google Scholar 11 Tucker MA, D'Angio GJ, Boice JD, Jr, et al.: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317: 588–593, 1987. 10.1056/NEJM198709033171002 CASPubMedWeb of Science®Google Scholar 12 Eng C, Li FP, Abramson DH, et al.: Mortality from second tumors among long term survivors of retinoblastoma. J Natl Cancer Inst 85: 1121–1128, 1993. 10.1093/jnci/85.14.1121 CASPubMedWeb of Science®Google Scholar 13 Pui C-H, Ribeiro RC, Hancock ML, et al.: Acute myeloid leukemia in children treated with epipodophyllotoxin for acute lymphoblastic leukemia. N Engl J Med 325: 1682–1687, 1991. 10.1056/NEJM199112123252402 PubMedWeb of Science®Google Scholar 14 Phillips RA, Gill RM, Zacksenhaus E, et al.: Why don't germline mutations in RB1 predispose to leukemia. Curr Top Microbiol Immunol 182: 485–491, 1992. 10.1007/978-3-642-77633-5_61 CASPubMedGoogle Scholar 15 Greenwald MJ, Strauss LC: Correspondence re: HSL Chan et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 2: 1499–1508, 1996 (Letter). PubMedWeb of Science®Google Scholar Clin Cancer Res 3: 491–92, 1997. CASPubMedWeb of Science®Google Scholar 16 Kuttesch JF, Parham DM, Luo X, Meyer WH, Bowman L, Shapiro DN, Pappo AS: P-glycoprotein expression at diagnosis does not correlate with response or outcome in childhood rhabdomyo-sarcoma. J Clin Oncol 14: 886–900, 1996. 10.1200/JCO.1996.14.3.886 CASPubMedWeb of Science®Google Scholar 17 Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of Pgp: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689–704, 1990. 10.1200/JCO.1990.8.4.689 PubMedWeb of Science®Google Scholar 18 Tose P, Clintorini M, Toti P, et al.: Histopathological evaluation for the prognosis of retinoblastoma. Ophthalmic Paediatr Genet 10: 173–177, 1989. 10.3109/13816818909009873 CASPubMedWeb of Science®Google Scholar 19 Shields CL, Shields JA, Baez KA, et al.: Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 77: 544–548, 1993. 10.1136/bjo.77.9.544 CASPubMedWeb of Science®Google Scholar 20 Shields CL, Shields JA, Baez K, et al.: Optic nerve invasion of retinoblastoma: Metastatic potential and clinical risk factors. Cancer 73: 692–698, 1994. 10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8 CASPubMedWeb of Science®Google Scholar 21 Haik BG, Dunleavy SA, Cooke C, et al.: Retinoblastoma with anterior chamber extension. Ophthalmic Res 94: 367–370, 1987. CASPubMedWeb of Science®Google Scholar 22 Doz F, Khelfaoui F, Mosseri V, et al.: The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. Cancer 74: 722–732, 1994. 10.1002/1097-0142(19940715)74:2<722::AID-CNCR2820740228>3.0.CO;2-H CASPubMedWeb of Science®Google Scholar 23 Maree-Berard P, Khelfaoui F, Frappez D, et al.: Prolonged remission in a child with late brain metastasis of retinoblastoma. Arch Pediatr 3: 1001–1005, 1996. PubMedWeb of Science®Google Scholar 24 Grabowski EF, Abramson DH.: Intraocular and extraocular retinoblastoma. Hematol Oncol Clin N Am 1: 721–735, 1987. 10.1016/S0889-8588(18)30649-X PubMedGoogle Scholar 25 Pratt CB, Fontanesi J, Chenaille P, et al.: Chemotherapy for extraocular retinoblastoma. Pediatr Hematol Oncol 11: 301–309, 1994. 10.3109/08880019409141673 CASPubMedWeb of Science®Google Scholar 26 Doz F, Neuenschwander S, Plantaz D, et al.: VP-16 and carboplatin in extraocular retinoblastoma. A study by the Societé Fran-caise d'Oncologie Pediatrique. J Clin Oncol 13: 902–909, 1995. CASPubMedWeb of Science®Google Scholar 27 Namouni F, Doz M, Tanguy ML, et al.: High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by hemopoietic stem cell rescue in patients with high-risk retinoblastoma: an SFOP and SFGM study. Eur J Cancer 33: 2368–2375, 1997. 10.1016/S0959-8049(97)10019-3 CASPubMedWeb of Science®Google Scholar 28 Berg S, Balis F, Zimm S, et al.: Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol 10: 143–148, 1992. 10.1200/JCO.1992.10.1.143 CASPubMedWeb of Science®Google Scholar Citing Literature Volume31, Issue6December 1998Pages 531-533 ReferencesRelatedInformation
Publication Year: 1998
Publication Date: 1998-12-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot